Monday 6 July 2020
Home      All news      Contact us     
healtheuropa - 2 month ago

Drug candidate as potential therapy for cytokine release syndrome

Preclinical proof of concept of PPP003 – a synthetic cannabinoid drug – has been put forward as potential therapy in the battle against COVID-19 through managing cytokine release syndrome. Tetra Bio-Pharma Inc., experts in cannabinoid-derived drug discovery and development, has announced it is adding a new indication in the development of PPP003. The new candidate [ ] The post Drug candidate as potential therapy for cytokine release syndrome appeared first on Health Europa.


Latest News
Hashtags:   

candidate

 | 

potential

 | 

therapy

 | 

cytokine

 | 

release

 | 

syndrome

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources